3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy.
Authors: Danesh Farhad R; Sadeghi Mehran M; Amro Nail; Philips Carrie; Zeng Lixia; Lin Sun; Sahai Atul; Kanwar Yashpal S;
Journal:Proc Natl Acad Sci U S A
PubMed ID:12048257
Inhibitors of 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase, also known as statins, are lipid-lowering agents widely used in the prevention of coronary heart disease. Recent experimental and clinical data, however, indicate that the overall benefits of statin therapy may exceed its cholesterol-lowering properties. We postulate that statins may ameliorate the detrimental effects ... More